Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs

 myTomorrows, the Dutch startup that wants to disrupt the way patients with unmet medical needs access development-stage treatments — drugs that are still undergoing clinical trials and working there way through a lengthy regulatory approval process — has raised €4.5 million (~$6m) in new funding. Read More